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of submaxillary gland: A case of reportYasutaka Hayashido a,*, Hideo Yoshioka b,1, Noriaki Tanaka b,1,
Yukio Yoshioka a,2, Hisataka Kitano a,2, Tomoaki Hamana a,2,
Koh-ichi Koizumi a,2, Tetsuji Okamoto a,2a Department of Molecular Oral Medicine and Maxillofacial Surgery, Division of Frontier Medical Science,
Graduate School of Biomedical Sciences, Hiroshima University, 1-2-3 Kasumi,
Minami-ku, Hiroshima 734-8553, Japan
b Department of Dentistry and Oral Surgery, Osaka Rosai Hospital, 1179-3 Nagasone-cho, Sakai,
Osaka 591-0825, JapanReceived 26 January 2005; accepted 26 January 2005Summary We report a case of dedifferentiated adenoid cystic carcinoma (ACC) of
the submaxillary gland. A 70 year-old female was referred with rapidly growing
tumor at the left cervical region. Tumor resection associated with radical neck dis-
section was performed. Subsequently, the patient underwent chemoradiation ther-
apy using cisplatin (CDDP) and 5-fluorouracil (5-FU), following the administration of
S-1, a novel oral derivative of 5-FU. The tumor was composed of aggregates of eosin-
ophilic hyalinized globules and undifferentiated carcinoma. The hyalinized globules
showed the immunoreactivity for laminin and type IV collagen. At present, no tumor
relapse and metastasis are observed.c 2005 Elsevier Ltd. All rights reserved.
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2 Tel.: +81 82 257 5668; fax: +81 82 257 5669.ing 10–15% of head and neck tumors. ACC is an
indolent tumor, and characterized with prolonged
clinical course such as slow growth and late onset
of metastasis.1 Histologically, ACC exhibits the dis-
tinctive features such as cribriform, tubular and
solid growth pattern, which are composed with
two cell types, ductal cells and myoepithelial cells.
Dedifferentiation is defined as histological pro-
gression of a low-grade malignant neoplasm to a
high-grade malignant neoplasm. Dedifferentiationved.
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plasms such as chondrosarcoma, liposarcoma
and osteosarcoma.2–4 Recent studies have dem-
onstrated dedifferentiation in several salivary
gland tumors such as acinic cell carcinoma, epithe-
lial–myoepithelial carcinoma and polymorphous
low-grade adenocarcinoma.5–8 ACC with dediffer-
entiation to high-grade malignant neoplasms is an
extremely rare with only about 6 cases reported
previously.9–11 In this article, we report a case of
dedifferentiated ACC of the submaxillary gland
with aggressive clinical behavior, and discuss the
histopathological features and treatment.Case report
A 70 year-old Japanese woman was referred to
Hiroshima University Dental Hospital because of
swelling in the left submaxillary region approxi-
mately with a 3 months history. Clinical examina-
tion revealed an elastic firm, expansile mass in
the left submaxillary region. Moreover, multipleFigure 1 CT showing a huge and low density tumor in the
nodes (arrow head), which were fused.lymphadenopathy was observed in the left cervical
region. Computed tomography (CT) scan of the
head and neck showed a large mass in the left sub-
maxillary gland and lymphadenopathy (Fig. 1).
Some lymph nodes were fused with the tumor of
the submaxillary gland. Thoracic and abdomen
CT, and gallium scintigraphy showed no tumoral le-
sion except the cervical lesion. Initially, the tumor
was considered to be adenocarcinoma or squamous
cell carcinoma of the submaxillary gland because
of its aggressive behavior. The patient underwent
composite resection of the submaxillary gland
accompanied with radical neck dissection. Subse-
quently, the patient underwent chemoradiation
using cisplatin (CDDP) and 5-fluorouracil (5-FU),
following the administration of S-1 (TS-1), a combi-
nation of ftorafur and two modulators, gimestat
(CDHP) and oxonic acid. Histopathological exami-
nation showed two distinctive components coex-
isted in the tumor (Fig. 2A). One component
consisted of large polygonal or cuboidal cells with
occasional mitoses and marked nuclear pleo-
morphism, indicating undifferentiated carcinomasubmaxillary region (arrow) and enlarged cervical lymph
Figure 2 Microscopic features of dedifferentiated ACC. Dedifferentiated area was juxtaposed with aggregates of
eosinophilic hyalinized globules (A). Dedifferentiated components were consisted of large polygonal or cuboidal cells
with frequent mitoses and marked nuclear pleomorphism (C). Eosinophilic hyalinized globules contained thin strands of
tumor cells. Cellular components were very scanty, and no tumor cells were observed in some eosinophilic hyalinized
globules (B). (Hematoxylin and eosin stain, original magnification A: x25; B, C: x125.)
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gates of eosinophilic hyalinized globules containing
thin strands of tumor cells, which was the architec-
ture characteristic of conventional ACC. Some
aggregates contained no tumor cells (Fig. 2C).
Immunohistochemical examination showed that
the aggregates of hyalinized globules were strongly
stained with anti-laminin antibody (Fig. 3A) and
anti-type IV collagen antibody (Fig. 3B). Therefore,
the final diagnosis for the present tumor was per-
formed as dedifferentiated ACC. No sign of local
recurrence and distant metastasis was noted 36
months after the treatment.Discussion
Dedifferentiation is histologic progression of a low-
grade malignant neoplasm to a high-grade malig-
nant neoplasm. Dedifferentiation was first shown
in chondrosarcoma, which was characterized by a
low-grade malignant chondrosarcoma juxtaposed
to a histologically different high-grade malignant
sarcoma.2 Subsequent studies have demonstrated
dedifferentiation in a variety of tumors such as lip-
osarcoma, osteosarcoma and papillary thyroid car-
cinoma.3,4,12,13 Recently, dedifferentiation has
been also proposed in a variety of salivary gland
Figure 3 Immunohistochemical staining for type IV collagen and laminin. The hyalinized globules were stained with
anti-type IV collagen antibody (A) and anti-laminin antibody (B). (Original magnification A, B: x70.)
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lial–myoepithelial carcinoma and polymorphous
low-grade adenocarcinoma.5–8 The onset of dedif-
ferentiation leads to an acquisition of aggressive-
ness with rapid growth and early onset of distant
metastases.
A variant of ACC, dedifferentiated ACC is extre-
mely rare. The clinical features of conventional
ACC are usually characterized by protracted course
with prolonged recurrence and late onset of metas-
tasis. The most common sites of distant metastases
were lung and bone, and cervical lymph node
metastasis is relatively rare. In contrast, the pres-
ent tumor showed rapid growth and early onset of
multiple lymph nodes metastasis, which apparently
differed from the clinical features of conventional
ACC. These clinical findings suggested that the
present tumor might be adenocarcinoma or squa-
mous cell carcinoma of the submaxillary gland,
but not conventional ACC.
Typical histological features of ACC are charac-
terized by cribriform, tubular and solid patterns,
which are composed of ductal cells and myoepithe-
lial cells. The present tumor demonstrated the
simultaneous presentation of two histologically dif-
ferent components, undifferentiated carcinoma
and aggregates of eosinophilic hyalinized globules.
It is well known that several salivary gland tumors
produce ECM proteins. ACC cells also produce a
large amount of extracellular matrix (ECM) pro-
teins, especially basement membrane components
such as laminin and type IV collagen. The accumu-
lation of ECM proteins in the intercellular spacesleads to the formation of pseudocyst, which is
the distinctive architecture of ACC. Occasionally,
the excessive production of basal lamina compo-
nents results in formation of eosinophilic hyaline
stroma containing few tumor cells, which was ob-
served in the present tumor. The aggregates of
hyalinized globules showed the immunoreactivity
for basement membrane components, laminin and
type IV collagen. These findings indicated that
the aggregates of eosinophilic hyalinized globules
were identified with the distinctive stromas of
ACC and the present tumor was ACC with dediffer-
entiation to a high-grade malignancy, undifferenti-
ated carcinoma.
Treatment for ACC is principally wide local
resection. Radiation therapy as an adjunct to
surgery has been shown to improve local control.
Chemotherapy has also been applied to ACC as the
additional treatment. The present tumor, which
exhibited clinically aggressive behavior, was histop-
athologically undifferentiated carcinoma in the
majority. The combination of radical surgery and
postoperative radiotherapy has been undertaken
for undifferentiated carcinoma of salivary gland tu-
mors to improve overall survival. Multiple lymph
node metastasis was observed in the present tumor,
and some of them were associated with extranodu-
lar tumor infiltration. Therefore, wide surgical
resection of the tumor and radical neck resection
were initially performed, and intensive chemoradi-
ation with the combination of cisplatin and 5-FU
was subsequently undertaken, following adminis-
tration of S-1, a novel oral derivative of 5-FU.
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